The Only Complete Online Marketing Firm
Wednesday, December 2, 2015
FDA Approves Second Antibody for Myeloma
(MedPage Today) -- Pivotal trial showed significant gain in PFS with elotuzumab
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment